Skip to content

TF effects on blood lipids

Effect of dietary Fenugreek seed powder on serum lipid profiles in patients with hyperlipidemia.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013111815452N1
Enrollment
40
Registered
2014-01-19
Start date
2014-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidaemia. Hyperlipidaemia, unspecified

Interventions

Intervention 1: in intevention Group each patient receive 5 grams of powdered fenugreek seeds daily for two months, with recommendations for lifestyle changes along this period. Intervention 2: contr
Treatment - Drugs
in intevention Group each patient receive 5 grams of powdered fenugreek seeds daily for two months, with recommendations for lifestyle changes along this period.
control Group only receive recommendations for lifestyle changes for two months.

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria: up to 18 years and less than 65 years old; an experiment with one of the following factors related to lipid LDL> 135 mg / dl; HDL 200 mg / dl; TG> 150 mg / dl. The exclusion criteria having underlying diseases such as diabetes, IHD, hypertension, metabolic syndrome, peripheral vascular disease, coronary artery disease and ...; LDL more than 190 in patients that need of medical treatment (for healthy people or with one risk factor); LDL = 160 in patient that need drug treatment (for those with two or more risk factors). Risk Factors: 1 - Smoking 2 - hypertension 3 - low HDL level (less than 40) 4 - history of coronary artery disease at an early age in the household (less than 55 years in males and in females under age 65years old) 5 - Age above 65 years. important point: diabetes mellitus, peripheral vascular disease and coronary artery disease are considered equivalent whit CAD. (CAD equivalent)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum lipid. Timepoint: in the begining of study and then after 2 month from the begining. Method of measurement: blood exam mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Yousefi

Qazvin University of Medical Science

elahehyousefi@yahoo.com+98 28 1336 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026